GMO crop pioneer Robb Fraley to leave Monsanto after Bayer takeover

Monsanto x
Credit: Robert Holly/Big-AgWatch.org

It’s the end of an era at Monsanto Co. after executives including the seed giant’s scientific leader Robb Fraley announced plans to depart after the company’s takeover by Germany’s Bayer AG.

Fraley will depart “shortly after closing” on the Bayer deal, following a transition period, Monsanto said Monday [May 8] in a statement. He has been at Monsanto for more than three decades and helped to invent genetically modified seeds, the company’s controversial technology that has come to define modern agriculture. The $66 billion takeover by Germany’s Bayer is expected to close during the current quarter.

…

Fraley has been the public face and champion of the science of GMOs. He joined the company as a 27-year-old, a Ph.D. in microbiology and biochemistry in hand, and worked on a team that found a way to insert foreign genes into plants. The result was Roundup Ready seeds, which could tolerate glyphosate, an herbicide that Monsanto manufactures under the brand Roundup.

The technology has transformed farming around the world. At the same time, it has inspired passionate protests among activists. Skepticism about such techniques remain despite a scientific consensus that supports the safety of eating genetically modified foods. Non-GMO labels on food have become commonplace in grocery stores.

Read full, original post: Face of GMOs at Monsanto to Step Down as Bayer Takeover Closes

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Sep-23-2026-02_36_39-PM
Viewpoint: After firing the entire National Science Board, Trump reshapes funding initiatives. Here’s the good and the bad.
ChatGPT-Image-Sep-10-2026-10_36_07-AM
Viewpoint: Even lousy scientific articles can shield authors when they hype dubious health claims and products
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
sorghum farmers in kenya FARMERS TREND
Here are all the ways CRISPR gene editing is transforming Africa’s staple crops—and there’s a lot more innovation to come
Screenshot-2026-10-01-at-11.21.27-AM
Vaccine hesitancy, like malaria, surges globally, topping 35% in some countries
ChatGPT-Image-Sep-30-2026-01_25_34-PM
Blood tests for Alzheimer’s? The latest grifter, social media scam.
ChatGPT-Image-Sep-30-2026-01_38_36-PM
Viewpoint: Died “with measles” vs. died “from measles”: RFK, Jr.’s dangerously subversive word games
ChatGPT-Image-Sep-30-2026-01_11_07-PM
How U.S. teamed with Russia to block global human AI weapons oversight
ChatGPT-Image-Sep-21-2026-03_15_09-PM
Viewpoint: Chipotle-inspired lesson: 10,000 sick customers suggest that processed foods can be safer than fresh ones
ChatGPT-Image-Sep-2-2026-02_03_32-PM
How much of a problem is AI’s water use?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.